Oklahoma Man Pleads Guilty To $8.2 Million K2 Conspiracy
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Oklahoma Man Pleads Guilty To $8.2 Million K2 Conspiracy

Oklahoma Man Pleads Guilty To $8.2 Million K2 Conspiracy

January 25, 2017
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Cynthia M. Velazquez
Phone Number: 571-324-7481

TULSA, Okla. - John Ray James of Dewey, pleaded guilty before United States District Judge Claire V. Egan to his role in a conspiracy related to the purchase and sale of $8.2 million of synthetic cannabinoids, also known as “K2,” at three retail smoke shops in Tulsa, Owasso and Claremore.  The plea was announced jointly by Drug Enforcement Administration-Dallas, Assistant Special Agent in Charge Richard Salter and U.S. Attorney Danny C. Williams, Sr.

“The successful conclusion of this investigation represents what can be achieved when law enforcement, the medical community, educators and concerned parents come together for the welfare of our children” said Salter.  “Synthetic cannabinoids are unpredictably dangerous and can be deadly.” 

At his change of plea hearing, James admitted that, from October 2011 to October 2014, he purchased for resale products falsely labeled as “potpourri,” “aromatherapy,” and “not for human consumption” which he knew contained synthetic drugs that customers purchased for human consumption.

“Synthetic drugs are a serious health threat that is especially dangerous to the young people of our communities,” said Williams.  “These synthetic drugs are sold with harmless sounding names to impressionable youth who are typically unaware of the harmful chemicals they are ingesting.  The chemicals in these drugs imported from China and Hong Kong are not approved for human consumption and have led to psychotic episodes, seizures and even death.”

Assistant Special Agent in Charge for the Internal Revenue Service-Dallas Field Office, Kelly Carpenter added, “Synthetic drugs represent a serious public health problem and are generally marketed toward teens and young adults.  The consumption of these illegal substances endangers young people around the country and can result in serious health issues, including death.  We are committed to working with our law enforcement partners to protect the public and to dismantle the drug organizations that promote the use of these toxic chemicals for their own financial gain.”

James will face a maximum penalty of five years in prison and a $250,000 fine.  In addition, James agreed to the forfeiture of seized funds in the amount $1.7 million.

The investigation is part of the Organized Crime Drug Enforcement Task (OCDETF) and High Intensity Drug Trafficking (HIDTA) programs led by the Drug Enforcement Administration, the Internal Revenue Service-Criminal Investigation and the Bureau of Indian Affairs.  The case is being prosecuted by Assistant United States Attorney Catherine J. Depew.

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Joseph B. Tucker Special Agent in Charge - Dallas
@DEADallasDiv
  • Facebook
  • X
  • Email
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster